Affinity in the News

Latest news

Protein A: expensive but effective say biopharma experts on both sides of the Atlantic


Protein A will continue to be a major cost for mAb manufacturers despite efforts to develop alternatives say experts.

Visit the original full article by Gareth MacDonald at BioPharma-Reporter.